ELAC2 Gene Prostate Cancer Hereditary Type 2 Susceptibility NGS Genetic DNA Test
Comprehensive Genetic Assessment for Prostate Cancer Risk
The ELAC2 Gene Prostate Cancer Hereditary Type 2 Susceptibility NGS Genetic DNA Test represents a breakthrough in personalized cancer risk assessment. This advanced genetic screening specifically targets the ELAC2 gene, which plays a critical role in mitochondrial RNA processing and has been identified as a significant contributor to hereditary prostate cancer susceptibility. By utilizing cutting-edge Next-Generation Sequencing technology, this test provides unparalleled accuracy in detecting genetic variations that may predispose individuals to developing prostate cancer.
What This Test Measures and Detects
The ELAC2 Gene Prostate Cancer test employs sophisticated NGS methodology to comprehensively analyze the entire ELAC2 gene sequence. This advanced approach enables detection of:
- Pathogenic mutations in the ELAC2 gene associated with hereditary prostate cancer type 2
- Single nucleotide variants (SNVs) that may impact gene function
- Insertions and deletions affecting protein structure
- Copy number variations that could influence cancer susceptibility
- Rare genetic variants with potential clinical significance
Who Should Consider This Genetic Test
This specialized genetic screening is particularly recommended for individuals who meet any of the following criteria:
- Men with a family history of prostate cancer, especially in first-degree relatives
- Individuals diagnosed with prostate cancer before age 55
- Those with multiple family members affected by prostate cancer across generations
- Men of African descent with family cancer history
- Individuals with family history of other ELAC2-associated cancers
- Those seeking proactive cancer risk assessment for informed health decisions
Key Benefits of ELAC2 Genetic Testing
Undergoing the ELAC2 Gene Prostate Cancer Susceptibility Test provides numerous advantages for comprehensive health management:
- Early Risk Identification: Detect genetic predisposition before cancer development
- Personalized Screening Protocols: Tailor prostate cancer screening frequency based on genetic risk
- Informed Family Planning: Understand inheritance patterns for future generations
- Proactive Health Management: Implement preventive measures and lifestyle modifications
- Psychological Relief: Reduce uncertainty through definitive genetic information
- Comprehensive Risk Assessment: Combine genetic data with other risk factors for holistic evaluation
Understanding Your Test Results
Your ELAC2 genetic test results will be carefully interpreted by our expert genetic counselors and oncologists. Results typically fall into three categories:
- Positive Result: Indicates the presence of a pathogenic ELAC2 mutation. This suggests increased prostate cancer risk and warrants enhanced screening and preventive measures.
- Negative Result: No known pathogenic mutations detected. While reassuring, this doesn’t eliminate all prostate cancer risk, as other genetic and environmental factors may contribute.
- Variant of Uncertain Significance (VUS): Identifies a genetic change with unknown clinical impact. Regular follow-up and family studies may be recommended.
Test Details and Pricing
| Test Information | Details |
|---|---|
| Test Name | ELAC2 Gene Prostate Cancer Hereditary Type 2 Susceptibility NGS Genetic DNA Test |
| Regular Price | $700 USD |
| Discount Price | $500 USD |
| Turnaround Time | 3 to 4 Weeks |
| Sample Type | Blood, Extracted DNA, or One Drop Blood on FTA Card |
| Testing Method | Next-Generation Sequencing (NGS) |
Pre-Test Requirements
Before undergoing the ELAC2 genetic test, patients must complete:
- Comprehensive clinical history documentation
- Genetic counseling session with certified genetic counselor
- Development of detailed family pedigree chart
- Informed consent process explaining test implications
Nationwide Accessibility
GGC DNA maintains testing facilities across all major metropolitan areas in the United States, including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our network ensures convenient access to advanced genetic testing services regardless of your location.
Take Control of Your Prostate Health Today
Understanding your genetic predisposition to prostate cancer empowers you to make informed decisions about your health. The ELAC2 Gene Prostate Cancer Hereditary Type 2 Susceptibility Test provides crucial information that can guide personalized screening, prevention strategies, and family planning. Don’t wait to gain insights into your genetic cancer risk profile.
Call or WhatsApp us today at +1(267) 388-9828 to schedule your genetic counseling session and book your ELAC2 genetic test. Our expert team is ready to guide you through every step of the testing process and help you understand your results for optimal health management.
